William Blair analyst Myles R. Minter reiterated an Outperform rating on Arcturus Therapeutics (NASDAQ: ARCT)The analyst comments "We see this ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE